Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PLPC
PLPC logo

PLPC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Preformed Line Products Co (PLPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
298.510
1 Day change
-4.68%
52 Week Range
324.550
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Preformed Line Products Co (PLPC) is not an ideal buy for a beginner investor with a long-term focus at this moment. While the technical indicators suggest a bullish trend, the lack of strong positive catalysts, declining financial performance in the latest quarter, and no recent trading signals make it prudent to wait for a better entry point or clearer long-term growth signals.

Technical Analysis

The technical indicators for PLPC show a bullish trend. The MACD histogram is positive and expanding (3.976), moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near resistance levels (R1: 314.921, R2: 330.067). However, the RSI is neutral at 74.674, and the stock's short-term trend suggests limited upside potential.

Positive Catalysts

  • Analysts have upgraded the stock to 'Buy' with a price target of $275, citing resilient demand and backlog growth. Technical indicators show a bullish trend.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 showed declining net income (-19.30% YoY), EPS (-19.25% YoY), and gross margin (-10.42% YoY). There are no significant trading trends from hedge funds or insiders, and no recent news or congress trading data to act as a positive catalyst.

Financial Performance

In Q4 2025, revenue increased by 3.59% YoY to $173.1M, but net income dropped by 19.30% YoY to $8.4M. EPS also declined by 19.25% YoY to 1.72, and gross margin fell to 29.82%, down 10.42% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Freedom Capital recently upgraded PLPC to 'Buy' from 'Hold' with a price target of $275, citing resilient demand and backlog growth. This suggests confidence in the company's long-term revenue visibility.

Wall Street analysts forecast PLPC stock price to rise
Analyst Rating
0
Wall Street analysts forecast PLPC stock price to rise
Buy
Hold
Sell
0
Current: 313.170
sliders
Low
0
Averages
0
High
0
0
Current: 313.170
sliders
Low
0
Averages
0
High
0
Freedom Capital
Hold -> Buy
upgrade
$221 -> $275
AI Analysis
2026-03-09
Reason
Freedom Capital
Price Target
$221 -> $275
AI Analysis
2026-03-09
upgrade
Hold -> Buy
Reason
Freedom Capital upgraded Preformed Line Products to Buy from Hold with a price target of $275, up from $221. The firm says the company's Q4 report confirmed it is seeing resilient demand and continued backlog growth. This offers solid revenue visibility for 2026, the analyst tells investors in a research note.

People Also Watch